Agnieszka Mizia-Malarz

Datos Biográficos

ID8267665
NOMBREAgnieszka Mizia-Malarz
NOMBRESAgnieszka
APELLIDOMizia-Malarz
FIRMAMIZIA-MALARZ A
AFILIACIONESMedical University of Silesia
VERIFICADONo
TOTAL DE OBRAS2
TOTAL DE CITAS0
TOTAL COMO AUTOR2
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2022
AÑO MÁS RECIENTE DE PUBLICACIÓN2026
ÍNDICE H0

  • The Outcomes of Myeloid Sarcoma in 64 Pediatric Patients and the Impact of Allogeneic Hematopoietic Stem Cell Transplantation on Treatment Results

    Open AccessMagdalena Samborska, Jolanta Skalska-Sadowska et al.ARTICLEChildren2026

    Background: Myeloid sarcoma (MS) is a malignant extramedullary tumor that occurs in patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or chronic myeloid leukemia (CML). The standard first-line treatment for MS is intensive chemotherapy according to the AML protocol, regardless of bone marrow involvement. The role of allogeneic hematopoietic stem cell transplantation (alloHSCT) in the treatment of pediatric patients with …

  • Relapses Children’s Acute Lymphoblastic Leukemia, Single Center Experience

    Open AccessWeronika Stolpa, Magdalena Zapała et al.ARTICLEChildren2022

    The prognosis in children and adolescents with relapsed ALL, despite intensive therapy, including hematopoietic stem cell transplantation, is still challenging. This study aims to analyze the incidence of relapsed ALL and survival rates in correlation to the risk factors. Materials and methods: 125 pediatric patients with ALL diagnosed in our department between 2000-2018; age 1−18 years old (median 6.4); female 53.6% vs. male 46.4%. Results: 19 p…